Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 2/20 | 0.51 |
| ▸ | RAMP3 | O60896 | 16/20 | 0.44 |
| ▸ | CALCR | P30988 | 16/20 | 0.44 |
| ▸ | GLP1R | P43220 | 1/20 | 0.41 |
| ▸ | GCGR | P47871 | 1/20 | 0.41 |
| ▸ | GIPR | P48546 | 1/20 | 0.41 |
| ▸ | GALR2 | O43603 | 1/20 | 0.41 |
| ▸ | GALR1 | P47211 | 1/20 | 0.41 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.41 |
| ▸ | RAMP2 | O60895 | 1/20 | 0.41 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16508596 | 0.77 | RAMP3 (0.53) | APLNRRAMP3CALCR | |
| SCHEMBL16508488 | 0.73 | APLNR (0.45) | APLNRRAMP3CALCR | |
| SCHEMBL29388041 | 0.73 | NPY2R (0.49) | CALCR | |
| SCHEMBL30933122 | 0.72 | APLNR (0.48) | APLNRRAMP3CALCR | |
| SCHEMBL17370235 | 0.72 | CAPN1 (0.52) | APLNRRAMP3CALCR | |
| SCHEMBL16508487 | 0.72 | NAA50 (0.48) | APLNRRAMP3CALCR | |
| SCHEMBL30933079 | 0.72 | APLNR (0.51) | APLNRRAMP3CALCR | |
| SCHEMBL29453464 | 0.70 | CALCR (0.50) | APLNRCALCR | |
| SCHEMBL17378292 | 0.70 | APLNR (0.47) | APLNRRAMP3CALCR | |
| SCHEMBL31297112 | 0.70 | APLNR (0.54) | APLNRRAMP3CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010053547-A2 | CXCR5 RECEPTOR COMPOUNDS | ANCHOR THERAPEUTICS, INC. (US) | 2010-05-14 | — | — | WO | disclosed |